Linagliptin in Post-renal Transplantation

NCT03970668 · clinicaltrials.gov ↗

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Transplanted Kidney Complication

Interventions

DRUG: Linagliptin 5 mg Oral Tablet
DRUG: Insulin

Sponsor

Universidad de Guanajuato

Collaborators

[object Object]